Clinical Trials Browser

Cholangiocarcinoma × envafolimab × 1 year × Clear all

NCT06643208 2025-06-26

D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC

Gastrointestinal

Cholangiocarcinoma